Rame Khasawneh, MD. Mohammad Maaytah, MD. Nagah Al Drous, MD. Ahmad Bani Salameh, MD. Bayan Alzgoul, MD. Mansour Hyari, MD. Nabeeha Abbasi, MD. Hala Alsoukni, MD. Asim Momani, MD.*


Background: Eosinophilia is associated with a large number of diseases and clinical conditions, but there is no information about the clinical characteristics of patients who are hospitalized due to this abnormality. The aim of this study is to determine the clinical profile and most informative diagnostic tests in patients hospitalized in a tertiary hospital with the finding of eosinophilia. Methods: This is a retrospective study that was done in the time period between January, 2015 till June, 2015 as a collaborative effort between Princess Iman Center for Laboratory Sciences and Research and the Internal Medicine Department/ King Hussein Medical City. Data was retrieved from the medical records of patients who were hospitalized with the finding of eosinophilia. All relevant data including clinical findings, laboratory tests, and imaging studies were analyzed. Results: A total of 130 patients were included in the study; (65 males and 60 females, with an age range between 26 and 60 years). The blood eosinophil absolute count was 2500-5600/μl (mean±SD) and this in the majority of cases persisted for a few months. The causes of the eosinophilia were:  Asthma or other atopic disease in 28patients (21.5%),  Pneumonia in 20 patients (15.4%),  Neoplastic diseases in 18 patients (13.8%),  Infections in12 patients (9.2%),  Skin diseases in 6 patients (4.6%),  Allergic drug reaction 5 patients (3.8%),  Hypereosinophilic syndrome in 1patient (0.77%),  And the cause was unknown in 40 patients (30.8%). Conclusion: Guidelines are needed for the investigation of patients hospitalized with eosinophilia, including the level of the eosinophilia associated with specific diseases and the most information yielding diagnostic tests.

Keywords: Eosinophilia, Allergy, Pneumonia, Neoplastic, Hypereosinophilic syndrome.

[Full Text Article]


Forgot Password  |  Register


Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation


    SEPTEMBER 2018 Issue has been successfully launched on 1 September 2018

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.


UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS


Copyright From

Covering Letter

                        Author Instruction